Epidemiology of clinically diagnosed Alzheimer's disease
- PMID: 3717905
- DOI: 10.1002/ana.410190502
Epidemiology of clinically diagnosed Alzheimer's disease
Abstract
This report reviews the current status of descriptive and analytic epidemiology of clinically diagnosed Alzheimer's disease (AD). Since AD can be diagnosed with certainty only at autopsy, currently available epidemiological data are based on a presumed clinical diagnosis. Current data indicate that AD represents a major health problem, at least in the developed countries. The prevalence ratio for AD ranges between 1.9 and 5.8 cases per 100 population aged 65 and over. Moreover, its prevalence is likely to increase in the next twenty years as a consequence of current demographic trends. The prevalence ratio for AD increases steeply with age and is higher in females. Incidence rates show a similar pattern, suggesting that AD should not be subdivided in a presenile and a senile form based on age of onset alone. Annual incidence rates of 2.4 cases per 100,000 population between ages 40 and 60, and 127 cases per 100,000 population after age 60 have been reported. Several case-control studies show that the occurrence of either dementia or Down's syndrome in other family members, advanced age of the mother at subject's birth, and head injury are possible risk factors.
Similar articles
-
The etiology of Alzheimer's disease: epidemiologic contributions with emphasis on the genetic hypothesis.J Neural Transm Suppl. 1987;24:3-12. J Neural Transm Suppl. 1987. PMID: 2960783 Review.
-
Frequency, distribution, and risk factors for Alzheimer's disease.Nurs Clin North Am. 1994 Mar;29(1):101-11. Nurs Clin North Am. 1994. PMID: 8121814 Review.
-
Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives.Ann Neurol. 1993 May;33(5):494-501. doi: 10.1002/ana.410330513. Ann Neurol. 1993. PMID: 8498827
-
[A case-control study of risk factors on Alzheimer's disease. Multicenter collaborative study in China].Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1992 Oct;25(5):284-7, 317. Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1992. PMID: 1291250 Chinese.
-
Risk factors for late-onset Alzheimer's disease: a population-based, case-control study.Ann Neurol. 1993 Mar;33(3):258-66. doi: 10.1002/ana.410330306. Ann Neurol. 1993. PMID: 8498809
Cited by
-
Gender, sex steroid hormones, and Alzheimer's disease.Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Horm Behav. 2013. PMID: 22554955 Free PMC article. Review.
-
Italian multicenter case-control study of clinically diagnosed Alzheimer disease: strategies and instruments for data collection.Ital J Neurol Sci. 1987 Apr;8(2):97-108. doi: 10.1007/BF02337582. Ital J Neurol Sci. 1987. PMID: 3597058
-
The dementing disorders.Psychiatr Q. 1997 Fall;68(3):261-79. doi: 10.1023/a:1025488324153. Psychiatr Q. 1997. PMID: 9237320 Review.
-
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.Genet Med. 2008 Mar;10(3):207-14. doi: 10.1097/GIM.0b013e318164e4cf. Genet Med. 2008. PMID: 18344711 Free PMC article. Clinical Trial.
-
Rodent models for Alzheimer's disease drug discovery.Expert Opin Drug Discov. 2015 Jul;10(7):703-11. doi: 10.1517/17460441.2015.1041913. Epub 2015 Apr 30. Expert Opin Drug Discov. 2015. PMID: 25927677 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical